Efficacy News and Research

RSS
Gene therapy can effectively treat ADA-deficient severe combined immunodeficiency

Gene therapy can effectively treat ADA-deficient severe combined immunodeficiency

ITM in Antwerp receives Gates Foundation grant for malaria research

ITM in Antwerp receives Gates Foundation grant for malaria research

FDA advisory committee votes in favor of Pfizer's tafamidis meglumine

FDA advisory committee votes in favor of Pfizer's tafamidis meglumine

Linagliptin safe and effective for African American patients with type 2 diabetes

Linagliptin safe and effective for African American patients with type 2 diabetes

Insmed initiates patient screening for ARIKACE phase 2 NTM lung disease trial

Insmed initiates patient screening for ARIKACE phase 2 NTM lung disease trial

LVRC safe and effective choice for patients with severe heterogeneous emphysema

LVRC safe and effective choice for patients with severe heterogeneous emphysema

Positive Results for Pulsar Stent in Clinical Study – BIOTRONIK announces

Positive Results for Pulsar Stent in Clinical Study – BIOTRONIK announces

Results from several studies related to ACT’s TEMPASURE cardiac ablation catheter

Results from several studies related to ACT’s TEMPASURE cardiac ablation catheter

Nevro to initiate Senza HF-SCS System study for chronic pain

Nevro to initiate Senza HF-SCS System study for chronic pain

Zytoprotec completes PD-protec Phase I/II trial on kidney failure

Zytoprotec completes PD-protec Phase I/II trial on kidney failure

Omron introduces new wireless sleep monitoring device

Omron introduces new wireless sleep monitoring device

Phase I/II clinical trial of novel dialysate completed by Zytoprotec

Phase I/II clinical trial of novel dialysate completed by Zytoprotec

AVEO commences AV-203 Phase 1 study in advanced solid tumors

AVEO commences AV-203 Phase 1 study in advanced solid tumors

Studies examine effectiveness of CPAP in reducing risk of cardiovascular outcomes linked with OSA

Studies examine effectiveness of CPAP in reducing risk of cardiovascular outcomes linked with OSA

Few new chemicals are in development for malaria vector control

Few new chemicals are in development for malaria vector control

HVTN opens enrollment in GeoVax’s GM-CSF adjuvanted vaccine Phase 1 trial for HIV

HVTN opens enrollment in GeoVax’s GM-CSF adjuvanted vaccine Phase 1 trial for HIV

Two-step method more effective tooth implant procedure

Two-step method more effective tooth implant procedure

Data from Alvine’s ALV003 Phase 2A trial on celiac disease presented at DDW 2012

Data from Alvine’s ALV003 Phase 2A trial on celiac disease presented at DDW 2012

Glytec receives FDA clearance for Glucommander 2.0 Enterprise software

Glytec receives FDA clearance for Glucommander 2.0 Enterprise software

Studies of technological innovations presented at DDW annual meeting

Studies of technological innovations presented at DDW annual meeting

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.